eviQ Education



eviQ Education eNews

 NEW! Rapid Learn + Listen package

Cytokine Release Syndrome (CRS)


CRS is an acute systemic inflammatory response, characterised by fever and in severe events can lead to multiple organ dysfunction. 
Severity of CRS ranges from mild to life-threatening, and when severe, is considered an oncological emergency.

Our rapid learning package includes a 5-minute mini-module to help you: 

  • Describe the signs and symptoms of CRS
  • Detail the assessment and immediate nursing interventions for CRS
  • Outline the investigations that may be undertaken in the diagnostic work-up for CRS
  • Identify management options for CRS

Learn more in the CRS rapid learning →


"He wasn’t at all behaving like himself, with increasing pain. That was our first sign that something was wrong." Nicola Mason, Paediatric Fellow

This Rapid Listening edition we hear a paediatric case study from fellow Nicola Mason, who describes the clinical presentation and treatment of a patient with cytokine release syndrome. 

Listen to the case study podcast →

Test your knowledge

Can you match possible symptoms of CRS with their severity? Or order the steps of a cytokine storm?

Reinforce your learning with a quick 2 minute mini-quiz, available as part of the oncological emergency series exclusive to the app.

Use the QR code to access to CRS mini quiz, or visit our mini quizzes homepage for more information.

New tool: Is it safe to treat your patient today?

Last month we launched the Day of Treatment (DOT) assessment tool and log sheet, a standardised risk assessment tool to help you evaluate and grade toxicities your patient may be experiencing on the day of treatment and escalate their care appropriately.

The release was done via a live webinar featuring expert speakers and live case studies.

The tool is accompanied by supportive resources, including videos demonstrating how to use the DOT assessment tool and log sheet, footage from the introductory webinar and five case studies.

Download the tool now!  →

ADAC update

We’ve reached some exciting milestones for ADAC V4...we've completed our first module! Module 1 focusses on safe handling and is currently with our wonderful Clinical Advisory Group! We've also completed content for modules 2 and 3, which are now being transformed by our brilliant design team. This has been a mammoth effort and we want to extend a very sincere thank you to the over 50 reviewers who cast their expert eye every step of the way. What happens now? Find out with the latest video update.

Keep up to date with our progress via the ADAC V4 page  →

 CVAD Facilitator training videos

We have developed a series of videos to help educators deliver the new CVADs course. The videos provide an overview of the course and outline the variety of resources and tools available within the package. The videos and specific facilitator tools - including competency assessment tools - can all be found in the facilitators toolbox page on eviQ Education.

CVAD tools for facilitators →

BMT course finished!

Our new five-part BMT course is complete! This was one of the most highly requested learning identified at our end of year survey in 2020, so thank you to those who alerted us to the learning need.

The course presents a complete overview of the haematological system, blood cancers, treatment with anti-cancer drug therapy and blood and marrow transplantation. It also featured as a poster presentation at the Blood 2021 ASM in September.

View the new BMT course  →

Course Update:  Physical activity for children living with cancer 

Are you new to paediatric oncology? This updated module is designed to promote the benefits of regular physical activity for children living with cancer by highlighting the different activity types and recommended dosage and the factors that affect a child’s ability to engage in physical activity.

Check out the updated course   →

Free webinar: Cancer in the pandemic

Join the next Cancer Conversation webinar on 9 November 2021 at 6pm AEST looking into the challenges, learnings and changes that the COVID19 pandemic has highlighted for cancer services.

Guest speakers include:

  • Professor Eva Segelov, Director of Oncology, Monash Health and Monash University
  • A/Prof Winston Liauw, Director of Cancer Services, South Eastern Sydney LHD
  • Dr Craig Underhill, Director of Cancer Services, Albury Wodonga Health and Clinical Director, Hume Regional Integrated Cancer Services

Register now →

Pharmacy ADAC – have your say!

Join us at the COSA CPG day on 15 November for a first look at the new ADAC Pharmacy – the landmark foundational course to support training for cancer pharmacists. The interactive session is open to pharmacists of all experience levels and we’re looking forward to getting on the ground input to ensure we successfully integrate Pharmacy ADAC into practice!

Register now →

Visit us virtually at COSA

Ask those burning questions, share your bright ideas or just come and have a look around our virtual booth at COSA this year. From 16 – 18 November 2021 we will be showcasing our new resources – as well as delivering a presentation to highlight the significant changes to assessing kidney function using eGFR, as part of the new guidelines for anticancer drug dosing in kidney dysfunction.

We will also have a virtual booth at CNSA Melbourne on 18 November - check us out!

We're finalists! 

We're excited to share we have been nominated as finalists in three categories for the premier accolade in the world of learning and talent - LearnX! The nominations are for our 24 Hour Telephone Triage toolkit package and our COVID-19 and Personal Protective Equipment rapid learning. Wish us luck!

CNSA Updates:

CNSA Vascular Access Devices: Evidence Based Clinical Practice Guidelines

The revised CNSA Vascular Access Devices: Evidence Based Clinical Practice Guidelines detail the latest evidence and recommendations for patients with cancer with peripheral intravenous cannulas and central venous access devices. Join us to celebrate the launch of these important guidelines on Wednesday 3 November! The first topic is Patency: Occlusion Prevention and Management. Eight common clinical questions are answered and graded recommendations for clinical practice. Find out what CNSA recommends for patency assessment, flushing and locking practices, needleless connectors and occlusion management and more.

Register now →

Cancer Nursing Workforce Survey

As the peak professional body for cancer nursing, the Cancer Nurses Society of Australia (CNSA) are leading an inaugural Australian project aiming to understand who and where cancer nurses in Australia are, and to identify their needs. This is the first time a national survey will provide a comprehensive picture of the working conditions and professional concerns of nurses who work exclusively in cancer care and control. We want to hear from you! – ten minutes of your time could lead to a huge amount of change.

 Help make a difference → 

eviQ updates

eviQ protocol updates

Subscribe to receive content area specific updates direct to your inbox - click here to sign up to eviQ newsletters.

eviQ also lists all recently added protocols and updates made in the past 90 days on their content area homepages: Cancer genetics Haematology and BMT Medical oncology Radiation oncologyClinical resources

eviQ →

As usual...

eviQ Education flyers available for your practice - Featuring a catalogue of all our courses. You can now print your own flyer to display in your workplace.

Rapid Learning series - New to Rapid learning? Browse our Rapid Learning library.

Rapid Listening series - Listen to our rapid learning series on our website, or listen/subscribe to the podcasts on Spotify or Google Podcasts.

Facilitator training: Register for on-demand facilitator training and/or an online Q & A session webinar:

  • ADAC Q & A session -  Wednesday 27th October 2021 at 2.00 - 3.00 pm (AEDT)
  • ADAC Q & A session -  Wednesday 24th November 2021 at 2.00 - 3.00 pm (AEDT)

View the training calendar here.

Email us on eviqed@eviq.org.au to receive training access or book your Q & A session and receive webinar login details.

 Want to know what's new? Keep an eye on our website newsfeed.

 Share the love: If you have a colleague who may be interested in receiving this update – please invite them to subscribe! If you have a link you'd like to share, think about tweeting it with hashtag #eviQ .



Q: "Is the new app free?"

A: Yes! The exclusive app is completely free and offers all new content using a fun interface! 

Download the free app →



Did you know?

The reported incidence of CRS triggered by CAR T-cell therapy has ranged from 30 - 100% and for grade 3 or 4 CRS, from 10 - 30%.

Learn more with our CRS rapid learning package →

Having trouble reading this update? View our online version here






Level 4,
1 Reserve Road,
St Leonards
Cammeraygal Country

Contact us  |  Unsubscribe